Key Sessions
Thomas Seewoester
PLENARY KEYNOTE: From Pipettes to Prompts: Accelerating Biomanufacturing at Exponential Velocity"
Amgen
Susan Sharfstein, PhD
KEYNOTE: Clonal variation and modulation of glycosylation in development of a biosimilar
University at Albany
Tracy Ryan
PLENARY KEYNOTE: From Immune Anarchy to Precision Healing: Sophie’s Journey and the Rise of NKore
NKore BioTherapeutics
Matthew Klinker
Keynote Presentation: Navigating Regulatory Frameworks for Cell and Gene Therapies
CBER, FDA
Kartik Subramanian, Ph.D.
PLENARY KEYNOTE: From Scale to Speed: Building the Next Era of Biologics Innovation
AbbVie
Anthony Davies, Ph.D.
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
Dark Horse Consulting Group Inc.
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Tuesday 16th September - Main Conference Day One - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Tuesday 16th September - Main Conference Day One - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Showing 1 of 1 Streams
Downstream Processing
11:10am - 11:15am
Chairperson Remarks: Downstream Processing
- Sanjay Nilapwar, Ph.D. - Principal Scientist I, Purification Development, BioProcess Development, Operations Science & Technology – Biologics, Abbvie
11:15am - 11:45am
Evaluation of Alternative Filtration Technologies for Improved Product Quality and Efficiency: Harvest RC, RCC and Polisher ST with a Linkage Comparison to a Platform
- Marc Schrader - Senior Scientist, Abbvie
11:45am - 12:15pm
Fireside Chat: Implementing Automation and Root Cause Analysis to save time in Downstream Processing
- A Representative - from, Regeneron
Showing 1 of 1 Streams
Downstream Processing
1:55pm - 2:00pm
Chairperson Remarks
- Sanjay Nilapwar, Ph.D. - Principal Scientist I, Purification Development, BioProcess Development, Operations Science & Technology – Biologics, Abbvie
2:00pm - 2:30pm
KEYNOTE: Developing Robust Downstream Processes for Complex Biologics
- Olga M. Paley, PhD - Director Purification Process Development, Takeda
2:30pm - 3:00pm
Uncharted ADC purification: characterization and raw material validation of a carbon filter for the removal of impurities in ADC manufacturing
- Christine Pham - Principal Scientist, Purification Process Development, Gilead
Showing 1 of 1 Streams
Downstream Processing
4:30pm - 5:30pm
Round Table Sessions
Round Table Session 1: Host Cell Proteins (HCPs): The Unseen Challenge
- Focus: Managing HCPs throughout the bioprocessing lifecycle.
- Key Discussion Points:
- HCP Characterization and Detection: Advancements in analytical methods for identifying and quantifying HCPs, including challenges with low-level detection and diverse HCP populations. Discuss the use of orthogonal methods.
- Impact of HCPs on Product Quality: Explore the mechanisms by which HCPs can affect product stability, efficacy, and immunogenicity. Focus on specific examples and case studies.
- HCP Removal Strategies: Evaluate current HCP removal technologies (chromatography, filtration) and discuss emerging approaches (e.g., novel resins, targeted removal). Consider the challenges of removing specific "high-risk" HCPs (lipases, proteases).
- HCP-Related Challenges in Different Product Modalities: Discuss specific HCP challenges associated with different types of biologics (e.g., antibodies, proteins, vaccines, cell therapies).
- Setting HCP Acceptance Criteria: How do we determine appropriate levels of HCPs, and what factors influence these decisions? Discuss the role of regulatory guidance.
- Future Directions in HCP Management: Explore innovative technologies and strategies for improved HCP control and monitoring. Discuss the role of AI/ML in predicting and managing HCP-related risks.
Round Table Session 2: Approach to complying with the latest FDA guidelines on Ethylene Glycol (EG) and Diethylene Glycol (DEG)
Roundtable Session 3: Polysorbate Degradation: Protecting Product Stability
- Focus: Understanding the mechanisms of polysorbate degradation and developing strategies to mitigate it.
- Key Discussion Points:
- Mechanisms of Polysorbate Degradation: Discuss the various pathways of polysorbate degradation, including hydrolysis, oxidation, and enzymatic degradation (with a focus on lipase contamination).
- Factors Influencing Degradation: Explore the factors that can influence polysorbate degradation, such as pH, temperature, oxygen levels, and the presence of specific HCPs (especially lipases).
- Analytical Methods for Monitoring Degradation: Discuss analytical techniques for detecting and quantifying polysorbate degradation products.
- Strategies for Mitigating Degradation: Explore strategies for preventing or minimizing polysorbate degradation, including process optimization, excipient selection, and the use of inhibitors.
- Impact of Polysorbate Degradation on Product Quality: Discuss the potential consequences of polysorbate degradation on product stability, efficacy, and safety.
- Case Studies of Polysorbate Degradation: Share real-world examples of polysorbate degradation challenges and the solutions implemented.
- Future Directions in Polysorbate Management: Explore new approaches for stabilizing polysorbates and preventing degradation, including the use of novel excipients and formulation strategies. Discuss the potential of more sensitive analytical methods.
- Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, North Carolina State University
- Derek Hubley - Director, Lonza
- Qin Gu - Process Development Senior Scientist, Amgen
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear